TR200002772T2 - Peroral etkin madde süspansiyonu - Google Patents

Peroral etkin madde süspansiyonu

Info

Publication number
TR200002772T2
TR200002772T2 TR2000/02772T TR200002772T TR200002772T2 TR 200002772 T2 TR200002772 T2 TR 200002772T2 TR 2000/02772 T TR2000/02772 T TR 2000/02772T TR 200002772 T TR200002772 T TR 200002772T TR 200002772 T2 TR200002772 T2 TR 200002772T2
Authority
TR
Turkey
Prior art keywords
active substance
substance suspension
small amounts
peroral
peroral active
Prior art date
Application number
TR2000/02772T
Other languages
English (en)
Inventor
Dietrich T�Rck Dr.
Veit Schmelmer Dr.
Original Assignee
Boehringer Ingelheim Pharma Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma Kg filed Critical Boehringer Ingelheim Pharma Kg
Publication of TR200002772T2 publication Critical patent/TR200002772T2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)

Abstract

Bulus NSAID tipinin, özellikle antiromatik meloksikam'in farmasötik etkin maddelerinin peroral olarak tatbik edilebilen; yüksek dagilimli silisyum-dioksit'ten az miktarda, büyük kesme kuvvetleri yardimi ile eklenmesi ve hidrofil polimerler'den az miktarlarda ilave edilmesi yoluyla, üç boyutlu bir siloit olusumunun meydana getirilmesi sureti ile stabilize edilen süspansiyonlari ve bunlarin imal edilmesine yönelik bir yöntem ile ilgilidir.
TR2000/02772T 1998-03-27 1999-03-23 Peroral etkin madde süspansiyonu TR200002772T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP98105568A EP0945131A1 (de) 1998-03-27 1998-03-27 Perorale Wirkstoff-Suspension

Publications (1)

Publication Number Publication Date
TR200002772T2 true TR200002772T2 (tr) 2000-12-21

Family

ID=8231651

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/02772T TR200002772T2 (tr) 1998-03-27 1999-03-23 Peroral etkin madde süspansiyonu

Country Status (26)

Country Link
EP (2) EP0945131A1 (tr)
JP (1) JP3323189B2 (tr)
KR (1) KR100587208B1 (tr)
CN (1) CN1150888C (tr)
AR (1) AR016196A1 (tr)
AT (1) ATE225648T1 (tr)
AU (1) AU762464B2 (tr)
BR (1) BR9909189A (tr)
CA (1) CA2326048C (tr)
CO (1) CO5070601A1 (tr)
DE (1) DE59903023D1 (tr)
DK (1) DK1066029T3 (tr)
ES (1) ES2184428T3 (tr)
HK (1) HK1034184A1 (tr)
HU (1) HU228474B1 (tr)
IL (1) IL137479A (tr)
MY (1) MY124599A (tr)
NO (1) NO321401B1 (tr)
NZ (1) NZ507610A (tr)
PL (1) PL192969B1 (tr)
PT (1) PT1066029E (tr)
TR (1) TR200002772T2 (tr)
TW (1) TWI232759B (tr)
UY (1) UY25443A1 (tr)
WO (1) WO1999049845A1 (tr)
ZA (1) ZA200003951B (tr)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8231899B2 (en) 1998-09-10 2012-07-31 Nycomed Danmark Aps Quick release pharmaceutical compositions of drug substances
US20020035107A1 (en) 2000-06-20 2002-03-21 Stefan Henke Highly concentrated stable meloxicam solutions
DE10161077A1 (de) 2001-12-12 2003-06-18 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion
US8992980B2 (en) 2002-10-25 2015-03-31 Boehringer Ingelheim Vetmedica Gmbh Water-soluble meloxicam granules
US20100297252A1 (en) 2003-03-03 2010-11-25 Elan Pharma International Ltd. Nanoparticulate meloxicam formulations
US8512727B2 (en) * 2003-03-03 2013-08-20 Alkermes Pharma Ireland Limited Nanoparticulate meloxicam formulations
EP1938803A3 (en) * 2003-03-03 2010-10-27 Elan Pharma International Limited Formulations comprising nanoparticulate meloxican
AU2003100262B4 (en) * 2003-04-07 2003-09-18 Jurox Pty Ltd Stable carprofen composition
US20050158367A1 (en) * 2004-01-16 2005-07-21 The Procter & Gamble Company Liquid compositions comprising one or more medicaments
EP1568369A1 (en) 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the treatment of respiratory diseases in pigs
WO2006042381A1 (en) * 2004-10-21 2006-04-27 Parnell Laboratories (Aust) Pty Limited Anti-inflammatory preparation
DK1824493T3 (da) * 2004-12-06 2008-12-08 Janssen Pharmaceutica Nv Oral suspension, der omfatter meloxicam
GB2438287A (en) * 2006-05-19 2007-11-21 Norbrook Lab Ltd Stable aqueous suspension
JP5559339B2 (ja) * 2009-10-12 2014-07-23 ベーリンガー インゲルハイム フェトメディカ ゲゼルシャフト ミット ベシュレンクテル ハフツング メロキシカムを含む組成物のための容器
CA2791805A1 (en) 2010-03-03 2011-09-09 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the long-term treatment of musculoskeletal disorders in cats
US20110218191A1 (en) * 2010-03-03 2011-09-08 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the long term-treatment of kidney disorders in cats
JP6092629B2 (ja) * 2010-03-10 2017-03-08 ルピン・リミテッドＬｕｐｉｎ Ｌｉｍｉｔｅｄ リファキシミン使用準備済懸濁液
CA2993363A1 (en) * 2010-03-19 2011-09-22 Boston Biomedical, Inc. Naphthofuran compounds and compositions for targeting cancer stem cells
US9795568B2 (en) 2010-05-05 2017-10-24 Boehringer Ingelheim Vetmedica Gmbh Low concentration meloxicam tablets
GB201117858D0 (en) 2011-10-17 2011-11-30 Norbrook Lab Ltd Paste
US20150192322A1 (en) * 2012-12-19 2015-07-09 Mitsubishi Electric Corporation Air conditioner
MX2017013715A (es) 2015-04-28 2018-03-02 Mars Inc Proceso de preparacion de un producto de alimento para mascotas humedo esterilizado.
KR102145022B1 (ko) * 2018-08-14 2020-08-14 동아제약 주식회사 이부프로펜의 현탁액 조성물 및 투여 제형
CN112044605B (zh) * 2019-06-06 2022-06-21 钟志勇 选钛药剂及选钛方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1196307B (it) * 1984-10-22 1988-11-16 Chiesi Farma Spa Formulazioni farmaceutiche acquose di piroxicam monoidrato
US4835187A (en) * 1987-06-15 1989-05-30 American Home Products Corporation Spray dried ibuprofen
JP2860729B2 (ja) * 1992-03-10 1999-02-24 エスエス製薬株式会社 プラノプロフェン懸濁シロップ剤
GB2318511A (en) * 1996-10-23 1998-04-29 Eurand Int Process for the preparation of a pharmaceutical composition for rapid suspension in water

Also Published As

Publication number Publication date
MY124599A (en) 2006-06-30
CO5070601A1 (es) 2001-08-28
HK1034184A1 (en) 2001-10-19
TWI232759B (en) 2005-05-21
IL137479A (en) 2005-09-25
HUP0102036A2 (hu) 2002-03-28
ZA200003951B (en) 2002-01-18
AU3147099A (en) 1999-10-18
KR20010042197A (ko) 2001-05-25
NO20004822D0 (no) 2000-09-26
EP1066029A1 (de) 2001-01-10
NO20004822L (no) 2000-11-23
WO1999049845A1 (de) 1999-10-07
EP0945131A1 (de) 1999-09-29
HUP0102036A3 (en) 2002-12-28
AR016196A1 (es) 2001-06-20
UY25443A1 (es) 1999-11-17
BR9909189A (pt) 2000-12-05
HU228474B1 (en) 2013-03-28
NZ507610A (en) 2003-08-29
ATE225648T1 (de) 2002-10-15
ES2184428T3 (es) 2003-04-01
DK1066029T3 (da) 2003-01-27
DE59903023D1 (en) 2002-11-14
JP3323189B2 (ja) 2002-09-09
PT1066029E (pt) 2003-02-28
IL137479A0 (en) 2001-07-24
CA2326048A1 (en) 1999-10-07
CA2326048C (en) 2008-08-12
PL192969B1 (pl) 2006-12-29
AU762464B2 (en) 2003-06-26
NO321401B1 (no) 2006-05-08
KR100587208B1 (ko) 2006-06-08
PL342345A1 (en) 2001-06-04
CN1150888C (zh) 2004-05-26
CN1295462A (zh) 2001-05-16
JP2002509875A (ja) 2002-04-02
EP1066029B1 (de) 2002-10-09

Similar Documents

Publication Publication Date Title
TR200002772T2 (tr) Peroral etkin madde süspansiyonu
IT1318539B1 (it) Composizioni farmaceutiche a rilascio prolungato per lasomministrazione parenterale di sostanze idrofile biologicamente
NO982364L (no) FremgangsmÕte for fremstilling av morfologisk anhetlige mikrokapsler, samt mikrokapsler fremstilt ved fremgangsmÕten
DK0961612T3 (da) Protein-stabiliserede-farmakologisk-aktive-midler og deres anvendelse
TR199901250T2 (tr) Tedavi amaçli ajanlar.
DK1553927T3 (da) Gel-stabiliserede, nanopartikulære aktivstof-sammensætninger
BR9808933A (pt) Composição sob forma de microcápsulas ou de implantes, processo de preparação de uma substância hidrossolúvel, substância ativa, acetato de triptorelina, acetato de lanreotìdeo, ou acetato de octreotìdeo, e rna de filamento duplo
DE59609451D1 (de) Feste wirkstoff-zubereitungen
TR200002059T2 (tr) Devamlı salınan bileşim, üretim yöntemi ve kullanımı.
DE69721489D1 (de) Herstellungsverfahren von löslichen verabreichungssystemen unter verwendung von flüchtigen salzen
TNSN04104A1 (fr) Formulations pharmaceutiques de derives de platine.
NO20032017D0 (no) Kjerne-skall partikler og fremgangsmåte for deres fremstilling
MA26888A1 (fr) Solutions moleculaires dispersees hydrophiles de carvedilol
CA2292586A1 (en) Solid pharmaceutical dosage forms in form of a particulate dispersion
FR2743562B1 (fr) Derives de n-(arylsulfonyl) aminoacides, leur preparation, les compositions pharmaceutiques en contenant
WO2002019969A3 (en) (5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents
ATE198152T1 (de) Oral anzuwendende arzneizubereitung mit verzögerter wirkstoffabgabe
BR0015256A (pt) Composições farmacêuticas contendo uma droga de antibiótico de fluoroquinolona e uma goma de xantano
TR199802289A2 (tr) Fosfonasit-ikame etmis benzazepinon-n-asetikasit türevleri.
IT1314185B1 (it) Composizione farmaceutica per somministrazione di sostanze attivescarsamente solubili in mezzi acquosi
ATE252375T1 (de) Bioabbaubare mikropartikeln mit verzögerter wirkstofffreisetzung
HK1038310A1 (en) Compositions and methods for treating intracellular infections.
BR9909357A (pt) Solução ou suspensão de mirtazapina em mistura com água, formulação farmacêutica compreendendo mirtazapina, e, uso de mirtazapina
SE9704400D0 (sv) Porous inorganic particles as carriers for drug substances
RS50348B (sr) Farmaceutski oblik dronedarona za parenteralnu upotrebu